Hints and tips:
Related Special Reports
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...Powell said investors worried that Pfizer had paid a lot for what it had bought....
...The jab’s variant formulation was approved by the US Food and Drug Administration earlier this month....
...Another said that the US drugmaker replaced the doses that had expired for free....
...BioNTech and Pfizer have described a similar patent filed in the US as “unimaginably broad” in American proceedings....
...Because for as long as many of us can remember, V-neck sweaters have been all but verboten — existing somewhere in the style hinterland between twisted jeans and square-toed tan leather loafers from Shoe...
...BlackRock is not the only US company to step up security spending on its chief executive.Disney chief Bob Iger’s 2023 pay package included $1.2mn in costs for “security services and equipment”, the entertainment...
...Pfizer shares tumbled more than 8 per cent after the US drugmaker forecast 2024 revenues that were below consensus estimates, as the company attempts to chart a future for growth without blockbuster Covid...
...Panuwat’s company, Medivation, was bought in 2016 by Pfizer for $14bn. But the stock he purchased at the time was not that of Medivation....
...The US government arranged with Pfizer to return 7.9mn Paxlovid courses at the end of 2023, at an estimated cost to the company of $4.2bn....
...US-based hedge fund Shah Capital wrote to the Novavax board on Monday to push for the instalment of two new independent board directors....
...Pfizer is abandoning its plans for a weight loss pill to be taken twice a day after trials showed it caused significant side effects, in a setback to the US drugmaker’s effort to enter the fast-growing market...
...The US federal drug regulator has approved new Covid-19 boosters from Moderna and Pfizer, as it moves to contain infections from spreading more quickly in the US....
...But, of course, there’s a reason why it’s widely called Shitibank; the sprawling, gormless Citi has for a v v v very long time proven adept at blithely ambling onto various rakes around the world....
...Yet Pfizer’s $19bn in Paxlovid sales were almost a fifth of its 2022 total....
...Pfizer and BioNTech each receive half of the gross profits of the vaccine. The US group plans to cut about $1bn in costs this year....
...US prosecutors have charged a former Pfizer employee, a Massachusetts police chief, a former pharmaceutical executive and investors in a Donald Trump media venture in separate insider trading cases, as part...
...Pfizer will keep the commercialisation rights outside the US and Japan. Roivant owns 75 per cent of Telavant, while Pfizer owns 25 per cent....
...His comments came after the US Federal Trade Commission on Tuesday sued to block Amgen’s $28bn takeover of Horizon Therapeutics....
...Manufacturers who do not comply with the negotiation process are liable to an excise tax, which starts at 65 per cent of a product’s sales in the US....
...The US drugmaker said revenues fell 29 per cent to $18.2bn in the three months to the end of March, compared with the same period last year, as Covid vaccine sales fell to $3.06bn, down from $13.2bn over...
...Shares in Pfizer added about 1 per cent on Friday, while Seagen was up about 0.9 per cent....
...Meanwhile Pfizer’s own shares, down more than a fifth this year, have underperformed peers....
...US pharmaceutical company Pfizer sold the shots, developed with Germany’s BioNTech, for about $19 a dose under the contract signed in 2021, but the new price has not been disclosed....
...Pfizer has agreed to acquire oncology-focused biotech Seagen for a total enterprise value of $43bn as the US pharmaceutical company refills its drugs pipeline amid a sharp fall in sales of its Covid-19 products...
International Edition